Reports

Sale

Intravascular Temperature Management Market

Global Intravascular Temperature Management Market Size, Price, Forecast: By Type: Intravascular Cooling, Intravascular Warming; By Medical Condition: Cardiac Arrest, Traumatic Brain Injury (TBI), Stroke, Myocardial Infection, Others; By Application: Pre-Operative Care, Operative Care, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Intravascular Temperature Management Market Outlook

The global intravascular temperature management market size was valued at USD 314.15 million in 2023, driven by the increasing prevalence of chronic diseases and ageing population across the globe. The market is anticipated to grow at a CAGR of 3.1% during the forecast period of 2024-2032 to achieve a value of USD 413.48 million by 2032.

 

Intravascular Temperature Management: Introduction

Intravascular temperature management is a technique that is used for the management of the body's core temperature while undergoing particular medical procedures or conditions. It is also known as cooling or warming technique in medical terms. The body temperature is managed by inserting the specialized catheters or devices into the blood vessels which helps in regulating the body's temperature by maintaining temperature of the blood stream. The main focus of intravascular temperature management technique is to maintain the patient's body temperature within a certain restricted range in order to improve recovery and patient's outcome.

 

Global Intravascular Temperature Management Market Analysis

Intravascular temperature management has multiple applications, depending upon the requirement of the condition. It can be used in multiple clinical settings, such as during the cardiac surgeries, post cardiac care, neurosurgeries, or sepsis, among others. It is also widely used in hypothermia, a condition where prominent organs of the body as brain and other organs are being protected from the effect of a cardiac arrest or traumatic brain injury by using the controlled cooling technique.

 

The several key trends running in the intravascular temperature management market expansion include the development of more advanced devices, such as catheters, with even better temperature control capabilities and easy to use devices. There is an escalating focus on the use of minimally invasive procedures and techniques in intravascular temperature management.

 

Minimally invasive procedures are known and preferred for their comparatively minimal incisions and to enable them even smaller equipment are required to be developed, hence the development of even smaller catheters and other devices with more flexibility and functionality is ongoing in the market. Some other key trends in the market include personalized temperature management, and involvement of new technologies along with research and studies owing to the intravascular temperature management market growth.

 

Global Intravascular Temperature Management Market Segmentations

Market Breakup by Type

  • Intravascular Cooling 
  • Intravascular Warming

 

Market Breakup by Medical Condition

  • Cardiac Arrest 
  • Traumatic Brain Injury (TBI) 
  • Stroke 
  • Myocardial Infection 
  • Others

 

Market Breakup by Application

  • Pre-Operative Care 
  • Operative Care 
  • Post-Operative Care 
  • Perioperative Care 
  • Acute/Critical Care

 

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global Intravascular Temperature Management Market Overview

The market for intravascular temperature management has seen evident growth in the past and is expected to be growing rapidly in coming years as well. The growth of the market is driven by various factors, including  the involvement of minimally invasive procedures. The increasing prevalence of the chronic diseases and increasing geriatric population has increased the demand for intravascular temperature management solutions in healthcare industry, propelling the intravascular temperature management market development.

 

Additionally, rapidly advancing technologies and utilization of new advanced devices in the procedure of temperature management has also increased the demand for intravascular temperature management in the market.

 

Intravascular Temperature Management Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Lonza Group 
  • Bio-Rad Laboratories, Inc. 
  • Thermo Fisher Scientific 
  • Qiagen NV 
  • Promega Corporation 
  • SignaGen Laboratories 
  • Merck KGaA 
  • Altogen Biosystems 
  • Polyplus-transfection SA 
  • Mirus Bio

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Medical Condition
  • Application
  • Region
Breakup by Type
  • Intravascular Cooling 
  • Intravascular Warming
Breakup by Medical Condition
  • Cardiac Arrest 
  • Traumatic Brain Injury (TBI) 
  • Stroke 
  • Myocardial Infection 
  • Others
Breakup by Application
  • Pre-Operative Care 
  • Operative Care 
  • Post-Operative Care 
  • Perioperative Care 
  • Acute/Critical Care
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Lonza Group 
  • Bio-Rad Laboratories, Inc. 
  • Thermo Fisher Scientific 
  • Qiagen NV 
  • Promega Corporation 
  • SignaGen Laboratories 
  • Merck KGaA 
  • Altogen Biosystems 
  • Polyplus-transfection SA 
  • Mirus Bio

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Intravascular Temperature Management Market Overview 

    3.1    Global Intravascular Temperature Management Market Historical Value (2017-2023) 
    3.2    Global Intravascular Temperature Management Market Forecast Value (2024-2032)
4    Global Intravascular Temperature Management Market Landscape
    4.1    Intravascular Temperature Management: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Intravascular Temperature Management: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Intravascular Temperature Management Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Intravascular Temperature Management Market Segmentation
    6.1    Global Intravascular Temperature Management Market by Type
        6.1.1    Market Overview    
        6.1.2    Intravascular Cooling
        6.1.3    Intravascular Warming
    6.2    Global Intravascular Temperature Management Market by Medical Condition
        6.2.1    Market Overview
        6.2.2    Cardiac Arrest
        6.2.3    Traumatic Brain Injury (TBI)
        6.2.4    Stroke
        6.2.5    Myocardial Infection
        6.2.6    Others
    6.3    Global Intravascular Temperature Management Market by Application
        6.3.1    Market Overview
        6.3.2    Pre-Operative Care
        6.3.3    Operative Care
        6.3.4    Post-Operative Care
        6.3.5    Perioperative Care
        6.3.6    Acute/Critical Care
    6.4    Global Intravascular Temperature Management Market by Region
        6.4.1    Market Overview
        6.4.2    North America
        6.4.3    Europe 
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Intravascular Temperature Management Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Intravascular Temperature Management Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Intravascular Temperature Management Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Intravascular Temperature Management Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Intravascular Temperature Management Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Lonza Group
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications 
    18.2    Bio-Rad Laboratories, Inc.
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Thermo Fisher Scientific
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Qiagen NV
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Promega Corporation
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    SignaGen Laboratories
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    Merck KGaA
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Altogen Biosystems
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Polyplus-transfection SA
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Mirus Bio
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket
    
    
*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 314.15 million in 2023, driven by increasing geriatric population.

The market is anticipated to grow at a CAGR of 3.1% during the forecast period of 2024-2032 to reach a market value of USD 413.48 million by 2032.

The increasing ageing population, and the increasing prevalence of chronic diseases are among the major factors driving the market growth.

The development of more advanced devices such as catheters with even better temperature control capabilities in the market is among the major trends in the market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The different types in the market includes intravascular cooling and intravascular warming.

The different medical conditions in the market include cardiac arrest, traumatic brain injury (TBI), stroke, and myocardial infection, among others.

It finds wide application in pre-operative care, operative care, post-operative care, perioperative care, and acute/critical care.

Key players involved in the market are Lonza Group, Bio-Rad Laboratories, Inc. Thermo Fisher Scientific, Qiagen NV, Promega Corporation, SignaGen Laboratories, Merck KGaA, Altogen Biosystems, Polyplus-transfection SA, and Mirus Bio.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER